The mechanism of bleomycin in inducing haemangioma regression
| dc.contributor.author | Mabeta, Peaceful Lucy | |
| dc.contributor.author | Davis, P.F. | |
| dc.contributor.email | peace.mabeta@up.ac.za | en_US |
| dc.date.accessioned | 2008-09-25T09:45:30Z | |
| dc.date.available | 2008-09-25T09:45:30Z | |
| dc.date.issued | 2008-07 | |
| dc.description.abstract | Haemangiomas are neoplasms of the vasculature frequently encountered in paediatrics which, although benign, may present with serious complications. The potential beneficial effects of intralesional bleomycin injection (IBI) in the treatment of haemangiomas were initially reported by Kullendorf and Sarihan et al. | en_US |
| dc.description.sponsorship | This study was funded by National Research Foundation and Bristol-Myers Squibb | en_US |
| dc.identifier.citation | Mabeta, P & Davis PF 2008, ‘The mechanism of bleomycin in inducing haemangioma regression’, South African Medical Journal, vol. 98, no. 7, pp. 538-539. [www.samj.org.za] | en_US |
| dc.identifier.issn | 0038-3469 | |
| dc.identifier.other | G-9725-2014 | |
| dc.identifier.other | 12791859400 | |
| dc.identifier.uri | http://hdl.handle.net/2263/7357 | |
| dc.language.iso | en | en_US |
| dc.publisher | Health and Medical Publishing Group | en_US |
| dc.rights | Health and Medical Publishing Group | en_US |
| dc.subject | Haemangioma | en_US |
| dc.subject | Neoplasms | en_US |
| dc.subject.lcsh | Pediatrics | |
| dc.subject.lcsh | Hemangiomas | |
| dc.subject.lcsh | Bleomycin | |
| dc.title | The mechanism of bleomycin in inducing haemangioma regression | en_US |
| dc.type | Article | en_US |